Silk-based stabilization of biomacromolecules

Journal of Controlled Release

Volumn 219, Issue , 2015, Pages 416-430

  Li, Adrian B ^a   Kluge, Jonathan A ^a   Guziewicz, Nicholas A ^b   Omenetto, Fiorenzo G ^a   Kaplan, David L ^a  

^a Tufts University   (United States)

^b AMGEN INC   (United States)

Author keywords

Biologics; Interactions; Mechanisms; Processing; Recovery; Silk; Stabilization

Indexed keywords

ANTIBODIES; BEAM PLASMA INTERACTIONS; MECHANISMS; MONOCLONAL ANTIBODIES; PROCESSING; RECOVERY; SILK;

BIOACTIVE MOLECULES; BIOLOGICS; BIOMACROMOLECULES; HIGH MOLECULAR WEIGHT; PROCESSING APPROACH; PROCESSING CONDITION; RELEASE KINETICS; SILK FIBROIN;

STABILIZATION;

ANTIBIOTIC AGENT; GLUCOSE OXIDASE; HORSERADISH PEROXIDASE; MEASLES VACCINE; MUMPS VACCINE; SILK; MACROMOLECULE;

ARTICLE; DRUG STABILITY; ENZYMATIC DEGRADATION; ENZYME STABILITY; FREEZE DRYING; HUMAN; HYDROPHOBICITY; HYPOTHESIS; MACROMOLECULE; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN QUATERNARY STRUCTURE; PROTEIN STABILITY; SOLID STATE; STATIC ELECTRICITY; SURFACE PROPERTY; CHEMISTRY;

DRUG STABILITY; MACROMOLECULAR SUBSTANCES; SILK;

EID: 84947203242     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2015.09.037     Document Type: Article

References (179)

1. G.H. Altman, R.L. Horan, H.H. Lu, J. Moreau, I. Martin, J.C. Richmond, and D.L. Kaplan Silk matrix for tissue engineered anterior cruciate ligaments Biomaterials 23 2002 4131 4141
2. G.H. Altman, F. Diaz, C. Jakuba, T. Calabro, R.L. Horan, J. Chen, H. Lu, J. Richmond, and D.L. Kaplan Silk-based biomaterials Biomaterials 24 2003 401 416
3. F.G. Omenetto, and D.L. Kaplan New opportunities for an ancient material Science 329 2010 528 531
4. S.W. Hwang, H. Tao, D.H. Kim, H. Cheng, J.K. Song, E. Rill, M.A. Brenckle, B. Panilaitis, S.M. Won, Y.S. Kim, Y.M. Song, K.J. Yu, A. Ameen, R. Li, Y. Su, M. Yang, D.L. Kaplan, M.R. Zakin, M.J. Slepian, Y. Huang, F.G. Omenetto, and J.A. Rogers A physically transient form of silicon electronics Science 337 2012 1640 1644
5. F.G. Omenetto, and D.L. KapLan A new route for silk Nat. Photonics 2 2008 641 643
6. X. Hu, D. Kaplan, and P. Cebe Determining beta-sheet crystallinity in fibrous proteins by thermal analysis and infrared spectroscopy Macromolecules 39 2006 6161 6170
7. C.Z. Zhou, F. Confalonieri, M. Jacquet, R. Perasso, Z.G. Li, and J. Janin Silk fibroin: structural implications of a remarkable amino acid sequence Proteins Struct. Funct. Genet. 44 2001 119 122
8. T. Arai, G. Freddi, R. Innocenti, and M. Tsukada Biodegradation of Bombyx mori silk fibroin fibers and films J. Appl. Polym. Sci. 91 2004 2383 2390
9. K. Numata, and D.L. Kaplan Silk-based delivery systems of bioactive molecules Adv. Drug Deliv. Rev. 62 2010 1497 1508
10. T. Yucel, M.L. Lovett, and D.L. Kaplan Silk-based biomaterials for sustained drug delivery J. Control. Release 190 2014 381 397
11. E.M. Pritchard, and D.L. Kaplan Silk fibroin biomaterials for controlled release drug delivery Expert Opin. Drug Deliv. 8 2011 797 811
12. E.M. Pritchard, P.B. Dennis, F. Omenetto, R.R. Naik, and D.L. Kaplan Review physical and chemical aspects of stabilization of compounds in silk Biopolymers 97 2012 479 498
13. D.N. Rockwood, R.C. Preda, T. Yucel, X. Wang, M.L. Lovett, and D.L. Kaplan Materials fabrication from Bombyx mori silk fibroin Nat. Protoc. 6 2011 1612 1631
14. H. Yamada, H. Nakao, Y. Takasu, and K. Tsubouchi Preparation of undegraded native molecular fibroin solution from silkworm cocoons Mater. Sci. Eng. C Biomim. Supramol. 14 2001 41 46
15. L.S. Wray, X. Hu, J. Gallego, I. Georgakoudi, F.G. Omenetto, D. Schmidt, and D.L. Kaplan Effect of processing on silk-based biomaterials: reproducibility and biocompatibility J. Biomed. Mater. Res. B Appl. Biomater. 99 2011 89 101
16. A. Matsumoto, J. Chen, A.L. Collette, U.J. Kim, G.H. Altman, P. Cebe, and D.L. Kaplan Mechanisms of silk fibroin sol-gel transitions J. Phys. Chem. B 110 2006 21630 21638
17. U.J. Kim, J. Park, C. Li, H.J. Jin, R. Valluzzi, and D.L. Kaplan Structure and properties of silk hydrogels Biomacromolecules 5 2004 786 792
18. T.T. Zainuddin, Y. Le, T.V. Park, P.J. Chirila, and A.K. Halley Whittaker, the behavior of aged regenerated Bombyx mori silk fibroin solutions studied by (1)H NMR and rheology Biomaterials 29 2008 4268 4274
19. Q. Lu, H. Zhu, C. Zhang, F. Zhang, B. Zhang, and D.L. Kaplan Silk self-assembly mechanisms and control from thermodynamics to kinetics Biomacromolecules 13 2012 826 832
20. S. Bai, H. Han, X. Huang, W. Xu, D.L. Kaplan, H. Zhu, and Q. Lu Silk scaffolds with tunable mechanical capability for cell differentiation Acta Biomater. 20 2015 22 31
21. D.L. Kaplan, J.A. KLUGE, F.G. Omenetto, Low Molecular Weight Silk Compositions and Stabilizing Silk Compositions, in, Google Patents, 2015.
22. D.-H. Kim, J. Viventi, J.J. Amsden, J. Xiao, L. Vigeland, Y.-S. Kim, J.A. Blanco, B. Panilaitis, E.S. Frechette, and D. Contreras Dissolvable films of silk fibroin for ultrathin conformal bio-integrated electronics Nat. Mater. 9 2010 511 517
23. H. Tao, B. Marelli, M. Yang, B. An, S. Onses, J.A. Rogers, D.L. Kaplan, and F.G. Omenetto Inkjet Printing of Regenerated Silk Fibroin: From Printable Forms to Printable Functions, Advanced Materials 2015
24. X. Wang, X. Hu, A. Daley, O. Rabotyagova, P. Cebe, and D.L. Kaplan Nanolayer biomaterial coatings of silk fibroin for controlled release J. Control. Release 121 2007 190 199
25. T. Asakura, A. Kuzuhara, R. Tabeta, and H. Saito Conformational characterization of Bombyx mori silk fibroin in the solid state by high-frequency carbon-13 cross polarization-magic angle spinning NMR, x-ray diffraction, and infrared spectroscopy Macromolecules 18 1985 1841 1845
26. S.J. He, R. Valluzzi, and S.P. Gido Silk I structure in Bombyx mori silk foams Int. J. Biol. Macromol. 24 1999 187 195
27. X. Tang, and M.J. Pikal Design of freeze-drying processes for pharmaceuticals: practical advice Pharm. Res. 21 2004 191 200
28. J.A. Kluge, B. Kahn, J. Brown, F.G. Omenetto, and D.L. Kaplan Optimizing Molecular Weight of Lyophilized Silk as a Shelf-Stable Source Material ACS Biomater. Sci. Eng. 2015 (in review)
29. J.F. Carpenter, M.J. Pikal, B.S. Chang, and T.W. Randolph Rational design of stable lyophilized protein formulations: some practical advice Pharm. Res. 14 1997 969 975
30. Q. Lu, X. Wang, X. Hu, P. Cebe, F. Omenetto, and D.L. Kaplan Stabilization and release of enzymes from silk films Macromol. Biosci. 10 2010 359 368
31. B.D. Lawrence, M. Cronin-Golomb, I. Georgakoudi, D.L. Kaplan, and F.G. Omenetto Bioactive silk protein biomaterial systems for optical devices Biomacromolecules 9 2008 1214 1220
32. K. Tsioris, W.K. Raja, E.M. Pritchard, B. Panilaitis, D.L. Kaplan, and F.G. Omenetto Fabrication of silk microneedles for controlled-release drug delivery Adv. Funct. Mater. 22 2012 330 335
33. J. Qian, Y. Liu, H. Liu, T. Yu, and J. Deng An amperometric new methylene blue N-mediating sensor for hydrogen peroxide based on regenerated silk fibroin as an immobilization matrix for peroxidase Anal. Biochem. 236 1996 208 214
34. M. Demura, T. Asakura, and T. Kuroo Immobilization of biocatalysts with Bombyx mori silk fibroin by several kinds of physical treatment and its application to glucose sensors Biosensors 4 1989 361 372
35. A. Kuzuhara, T. Asakura, R. Tomoda, and T. Matsunaga Use of silk fibroin for enzyme membrane J. Biotechnol. 5 1987 199 207
36. S. Lu, X. Wang, Q. Lu, X. Hu, N. Uppal, F.G. Omenetto, and D.L. Kaplan Stabilization of enzymes in silk films Biomacromolecules 10 2009 1032 1042
37. P.B. Dennis, A.Y. Walker, M.B. Dickerson, D.L. Kaplan, and R.R. Naik Stabilization of organophosphorus hydrolase by entrapment in silk fibroin: formation of a robust enzymatic material suitable for surface coatings Biomacromolecules 13 2012 2037 2045
38. J. Zhang, E. Pritchard, X. Hu, T. Valentin, B. Panilaitis, F.G. Omenetto, and D.L. Kaplan Stabilization of vaccines and antibiotics in silk and eliminating the cold chain Proc. Natl. Acad. Sci. U. S. A. 109 2012 11981 11986
39. T.D. Sutherland, A. Sriskantha, J.S. Church, T. Strive, H.E. Trueman, and T. Kameda Stabilization of viruses by encapsulation in silk proteins ACS Appl. Mater. Interfaces 6 2014 18189 18196
40. Y.H. Wu, Q.C. Shen, and S.S. Hu Direct electrochemistry and electrocatalysis of heme-proteins in regenerated silk fibroin film Anal. Chim. Acta 558 2006 179 186
41. P. Domachuk, H. Perry, J.J. Amsden, D.L. Kaplan, and F.G. Omenetto Bioactive "self-sensing" optical systems Appl. Phys. Lett. 95 2009
42. J.G. Hardy, L.M. Romer, and T.R. Scheibel Polymeric materials based on silk proteins Polymer 49 2008 4309 4327
43. K. Schacht, and T. Scheibel Processing of recombinant spider silk proteins into tailor-made materials for biomaterials applications Curr. Opin. Biotechnol. 29 2014 62 69
44. S. Gomes, I.B. Leonor, J.F. Mano, R.L. Reis, and D.L. Kaplan Spider silk-bone sialoprotein fusion proteins for bone tissue engineering Soft Matter 7 2011 4964 4973
45. J. Huang, C. Wong, A. George, and D.L. Kaplan The effect of genetically engineered spider silk-dentin matrix protein 1 chimeric protein on hydroxyapatite nucleation Biomaterials 28 2007 2358 2367
46. A. Lammel, M. Schwab, M. Hofer, G. Winter, and T. Scheibel Recombinant spider silk particles as drug delivery vehicles Biomaterials 32 2011 2233 2240
47. M. Hofer, G. Winter, and J. Myschik Recombinant spider silk particles for controlled delivery of protein drugs Biomaterials 33 2012 1554 1562
48. K. Numata, A.J. Mieszawska-Czajkowska, L.A. Kvenvold, and D.L. Kaplan Silk-based nanocomplexes with tumor-homing peptides for tumor-specific gene delivery Macromol. Biosci. 12 2012 75 82
49. C. Blum, A. Nichtl, and T. Scheibel Spider silk capsules as protective reaction containers for enzymes Adv. Funct. Mater. 24 2014 763 768
50. T.D. Rapson, J.S. Church, H.E. Trueman, H. Dacres, T.D. Sutherland, and S.C. Trowell Micromolar biosensing of nitric oxide using myoglobin immobilized in a synthetic silk film Biosens. Bioelectron. 62 2014 214 220
51. W.W. Huang, A. Rollett, and D.L. Kaplan Silk-elastin-like protein biomaterials for the controlled delivery of therapeutics Expert Opin. Drug Deliv. 12 2015 779 791
52. D. Liu, D. Ren, H. Huang, J. Dankberg, R. Rosenfeld, M.J. Cocco, L. Li, D.N. Brems, and R.L. Remmele Jr. Structure and stability changes of human IgG1 Fc as a consequence of methionine oxidation Biochemistry 47 2008 5088 5100
53. Q. Luo, M.K. Joubert, R. Stevenson, R.R. Ketchem, L.O. Narhi, and J. Wypych Chemical modifications in therapeutic protein aggregates generated under different stress conditions J. Biol. Chem. 286 2011 25134 25144
54. F. Mulinacci, M.A.H. Capelle, R. Gurny, A.F. Drake, and T. Arvinte Stability of human growth hormone: influence of methionine oxidation on thermal folding J. Pharm. Sci. 100 2011 451 463
55. A.A. Wakankar, R.T. Borchardt, C. Eigenbrot, S. Shia, Y.J. Wang, S.J. Shire, and J.L. Liu Aspartate isomerization in the complementarity-determining regions of two closely related monoclonal antibodies Biochemistry 46 2007 1534 1544
56. E.J. McNally Protein Formulation and Delivery 2000 Marcel Dekker, Inc. New York
57. A.L. Daughery, and R.J. Mrsny Formulation and delivery issues for monoclonal antibody therapeutics Adv. Drug Deliv. Rev. 58 2006 686 706
58. A. Hawe, M. Wiggenhorn, M. van de Weert, J.H.O. Garbe, H.-C. Mahler, and W. Jiskoot Forced degradation of therapeutic proteins J. Pharm. Sci. 101 2012 895 913
59. W. Jiskoot, T.W. Randolph, D.B. Volkin, C.R. Middaugh, C. Schoneich, G. Winter, W. Friess, D.J. Crommelin, and J.F. Carpenter Protein instability and immunogenicity: roadblocks to clinical application of injectable protein delivery systems for sustained release J. Pharm. Sci. 101 2012 946 954
60. M.C. Manning, D.K. Chou, B.M. Murphy, R.W. Payne, and D.S. Katayama Stability of protein pharmaceuticals: an update Pharm. Res. 27 2010 544 575
61. H.C. Mahler, W. Friess, U. Grauschopf, and S. Kiese Protein aggregation: pathways, induction factors and analysis J. Pharm. Sci. 98 2009 2909 2934
62. B.S. Chang, and B. Yeung Physical stability of protein pharmaceuticals F. Jameel, S. Hershenson, Formulation and Process Development Strategies for Manufacturing Biopharmaceuticals 2010 John Wiley & Sons Hoboken, New Jersey 69 104
63. M.E.M. Cromwell, E. Hilario, and F. Jacobson Protein aggregation and bioprocessing AAPS J. 8 2006 573 579
64. P.L. Privalov Stability of proteins. Proteins which do not present a single cooperative system Adv. Protein Chem. 35 1982 1 104
65. R. Jaenicke Stability and stabilization of globular proteins in solution J. Biotechnol. 79 2000 193 203
66. B. Perez-Ramirez, N. Guziewicz, and B.R. Simler Preformulation research: assessing protein solution behavior during early development F. Jameel, S. Hershenson, Formulation and Process Development Strategies for Manufacturing Biopharmaceuticals 2010 John Wiley & Sons Hoboken, New Jersey 119 146
67. V.K. Mulligan, A. Kerman, R.C. Laister, P.R. Sharda, P.E. Arslan, and A. Chakrabartty Early steps in oxidation-induced SOD1 misfolding: implications for non-amyloid protein aggregation in familial ALS J. Mol. Biol. 421 2012 631 652
68. E.Y. Chi, S. Krishnan, T.W. Randolph, and J.F. Carpenter Physical stability of proteins in aqueous solution: mechanism and driving forces in nonnative protein aggregation Pharm. Res. 20 2003 1325 1336
69. S.N. Timasheff Control of protein stability and reactions by weakly interacting cosolvents: the simplicity of the complicated Adv. Protein Chem. 51 51 1998 355 432
70. S.N. Timasheff The control of protein stability and association by weak-interactions with water - how do solvents affect these processes Annu. Rev. Biophys. Biomol. 22 1993 67 97
71. J.J. Valente, R.W. Payne, M.C. Manning, W.W. Wilson, and C.S. Henry Colloidal behavior of proteins: effects of the second virial coefficient on solubility, crystallization and aggregation of proteins in aqueous solution Curr. Pharm. Biotechnol. 6 2005 427 436
72. D. Asthagiri, B.L. Neal, and A.M. Lenhoff Calculation of short-range interactions between proteins Biophys. Chem. 78 1999 219 231
73. J.R. Alford, B.S. Kendrick, J.F. Carpenter, and T.W. Randolph Measurement of the second osmotic virial coefficient for protein solutions exhibiting monomer-dimer equilibrium (vol 377, pg 128, 2008) Anal. Biochem. 383 2008 349
74. S. Yadav, T.M. Laue, D.S. Kalonia, S.N. Singh, and S.J. Shire The influence of charge distribution on self-association and viscosity behavior of monoclonal antibody solutions Mol. Pharm. 9 2012 791 802
75. J. Jezek, M. Rides, B. Derham, J. Moore, E. Cerasoli, R. Simler, and B. Perez-Ramirez Viscosity of concentrated therapeutic protein compositions Adv. Drug Deliv. Rev. 63 2011 1107 1117
76. S.V. Sule, J.K. Cheung, V. Antochshuk, A.S. Bhalla, C. Narasimhan, S. Baisdell, M. Shameem, and P.M. Tessier Solution pH that minimizes self-association of three monoclonal antibodies is strongly dependent on ionic strength Mol. Pharm. 9 2012 744 751
77. S. Yadav, S.J. Shire, and D.S. Kalonia Viscosity behavior of high-concentration monoclonal antibody solutions: correlation with interaction parameter and electroviscous effects J. Pharm. Sci. 101 2012 998 1011
78. H. Fan, J. Liu, W. Ren, Z. Zheng, Y. Zhang, X. Yang, H. Li, X. Wang, and G. Zou pH induces thermal unfolding of UTI: an implication of reversible and irreversible mechanism based on the analysis of thermal stability, Thermodynamic, Conformational Characterization J. Fluoresc. 18 2008 305 317
79. K.J. Ellis, and J.F. Morrison Buffers of constant ionic strength for studying pH-dependent processes Methods Enzymol. 87 1982 405 426
80. D.S. Katayama, R. Nayar, D.K. Chou, J.J. Valente, J. Cooper, C.S. Henry, D.G. Vander Velde, L. Villarete, C.P. Liu, and M.C. Manning Effect of buffer species on the thermally induced aggregation of interferon-tau J. Pharm. Sci. 95 2006 1212 1226
81. D. Kameoka, E. Masuzaki, T. Ueda, and T. Imoto Effect of buffer species on the unfolding and the aggregation of humanized IgG J. Biochem. 142 2007 383 391
82. J. Jezek, D.X. Chen, L. Watson, J. Crawford, S. Perkins, A. Tyagi, and L. Jones-Braun A heat-stable hepatitis B vaccine formulation Hum. Vaccines 5 2009 529 535
83. J. Jezek Increasing the protein stability of an aqueous composition comprising a protein by determining a pH at which the protein has stability, adding a displacement buffer, and adjusting the pH of the composition, in, ARECOR LTD (AREC-Non-standard) JEZEK J (JEZE-Individual) 2008 pp. 2114456-A2114452
84. T. Arakawa, and S.N. Timasheff Stabilization of protein structure by sugars Biochemistry 21 1982 6536 6544
85. J.C. Lee, and S.N. Timasheff The stabilization of proteins by sucrose J. Biol. Chem. 256 1981 7193 7201
86. R. Bhat, and S.N. Timasheff Steric exclusion is the principal source of the preferential hydration of proteins in the presence of polyethylene glycols Protein Sci. 1 1992 1133 1143
87. K. Gekko, and S.N. Timasheff Mechanism of protein stabilization by glycerol: preferential hydration in glycerol-water mixtures Biochemistry 20 1981 4667 4676
88. B.M. Baynes, D.I.C. Wang, and B.L. Trout Role of arginine in the stabilization of proteins against aggregation Biochemistry 44 2005 4919 4925
89. T. Arakawa, D. Ejima, K. Tsumoto, N. Obeyama, Y. Tanaka, Y. Kita, and S.N. Timasheff Suppression of protein interactions by arginine: a proposed mechanism of the arginine effects Biophys. Chem. 127 2007 1 8
90. B.A. Kerwin Polysorbates 20 and 80 used in the formulation of protein biotherapeutics: structure and degradation pathways J. Pharm. Sci. 2007 1 12
91. E.M. Topp, L. Zhang, H. Zhao, R.W. Payne, G.J. Evans, and M.C. Manning Chemical instability in peptide and protein pharmaceuticals F. Jameel, S. Hershenson, Formulation and Process Development Strategies for Manufacturing Biopharmaceuticals 2010 John Wiley & Sons Hoboken, New Jersey 41 67
92. H. Liu, G. Gaza-Bulseco, and J. Sun Characterization of the stability of a fully human monoclonal IgG after prolonged incubation at elevated temperature J. Chromatogr. B 837 2006 35 43
93. B. Peters, and B.L. Trout Asparagine deamidation: pH-dependent mechanism from density functional theory Biochemistry 45 2006 5384 5392
94. A.A. Wakankar, and R.T. Borchardt Formulation considerations for proteins susceptible to asparagine deamidation and aspartate isomerization J. Pharm. Sci. 95 2006 2321 2336
95. K. Patel, and R.T. Borchardt Chemical pathways of peptide degradation. II. Kinetics of deamidation of an asparaginyl residue in a model hexapeptide Pharm. Res. 7 1990 703 711
96. W. Zhang, M.J. Czupryn, P.T. Boyle, and J. Amari Characterization of asparagine deamidation and aspartate isomerization in recombinant human interleukin-11 Pharm. Res. 19 2002 1223 1231
97. R.T.B. Aditya, and A. Wakankar Formulation considerations for proteins susceptible to asparagine deamidation and aspartate isomerization J. Pharm. Sci. 95 2006 2321 2336
98. A.S. Inglis Cleavage at aspartic-acid Methods Enzymol. 91 1983 324 332
99. B.J. Marsden, T.M. Nguyen, and P.W. Schiller Spontaneous degradation via diketopiperazine formation of peptides containing a tetrahydroisoquinoline-3-carboxylic acid residue in the 2-position of the peptide sequence Int. J. Pept. Protein Res. 41 1993 313 316
100. L. Yu, A. Vizel, M.B. Huff, M. Young, R.L. Remmele Jr., and B. He Investigation of N-terminal glutamate cyclization of recombinant monoclonal antibody in formulation development J. Pharm. Biomed. Anal. 42 2006 455 463
101. E.R. Stadtman Metal ion-catalyzed oxidation of proteins: biochemical mechanism and biological consequences Free Radic. Biol. Med. 9 1990 315 325
102. C. Schoneich Mechanisms of metal-catalyzed oxidation of histidine to 2-oxo-histidine in peptides and proteins J. Pharm. Biomed. Anal. 21 2000 1093 1097
103. E.R. Stadtman Oxidation of free amino-acids and amin-acid residues in proteins by radiolysis and by metal-catalyzed reactions Annu. Rev. Biochem. 62 1993 797 821
104. C.L. Hawkins, and M.J. Davies Generation and propagation of radical reactions on proteins Biochim. Biophys. Acta Bioenerg. 1504 2001 196 219
105. H. Liu, G. Gaza-Bulseco, and L. Zhou Mass spectrometry analysis of photo-induced methionine oxidation of a recombinant human monoclonal antibody J. Am. Soc. Mass Spectrom. 20 2009 525 528
106. E.T. Duenas, R. Keck, A. De Vos, A.J.S. Jones, and J.L. Cleland Comparison between light induced and chemically induced oxidation of rhVEGF Pharm. Res. 18 2001 1455 1460
107. S. Horvat, and A. Jakas Peptide and amino acid glycation: new insights into the maillard reaction J. Pept. Sci. 10 2004 119 137
108. S.A. Hill, W. MacNaughtan, I.A. Farhat, T.R. Noel, R. Parker, S.G. Ring, and M.J. Whitcombe The effect of thermal history on the maillard reaction in a glassy matrix J. Agric. Food Chem. 53 2005 10213 10218
109. T. Geiger, and S. Clarke Deamidation, isomerization, and racemization at asparaginyl and aspartyl residues in peptides. Succinimide-linked reactions that contribute to protein degradation J. Biol. Chem. 262 1987 785 794
110. M.C. Manning, K. Patel, and R.T. Borchardt Stability of protein pharmaceuticals Pharm. Res. 6 1989 903 918
111. H.T. Wright Nonenzymatic deamidation of asparaginyl and glutaminyl residues in proteins Crit. Rev. Biochem. Mol. Biol. 26 1991 1 52
112. S.J. Wearne, and T.E. Creighton Effect of protein conformation on rate of deamidation: ribonuclease A Proteins 5 1989 8 12
113. J. Fransson, E. Florin-Robertsson, K. Axelsson, and C. Nyhlen Oxidation of human insulin-like growth factor I in formulation studies: kinetics of methionine oxidation in aqueous solution and in solid state Pharm. Res. 13 1996 1252 1257
114. C.S.R.T.B. Shihong Li Chemical instability of protein pharmaceuticals: Mechanisms of oxidation and strategies for stabilization Biotechnol. Bioeng. 48 1995 490 500
115. M.T. Fisher, and E.R. Stadtman Oxidative modification of Escherichia-coli glutamine-synthetase - decreases in the thermodynamic stability of protein-structure and specific changes in the active-site conformation J. Biol. Chem. 267 1992 1872 1880
116. N.A. Guziewicz, A.J. Massetti, B.J. Perez-Ramirez, and D.L. Kaplan Mechanisms of monoclonal antibody stabilization and release from silk biomaterials Biomaterials 34 2013 7766 7775
117. ab stabilities within a host of therapeutic IgGs Biochem. Biophys. Res. Commun. 355 2007 751 757
118. K.A. Pikal-Cleland, N. Rodriguez-Hornedo, G.L. Amidon, and J.F. Carpenter Protein denaturation during freezing and thawing in phosphate buffer systems: monomeric and tetrameric beta-galactosidase Arch. Biochem. Biophys. 384 2000 398 406
119. L.L. Chang, D. Shepherd, J. Sun, D. Ouellette, K.L. Grant, X.C. Tang, and M.J. Pikal Mechanism of protein stabilization by sugars during freeze-drying and storage: native structure preservation, specific interaction, and/or immobilization in a glassy matrix? J. Pharm. Sci. 94 2005 1427 1444
120. M. Stefani, and C.M. Dobson Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution J. Mol. Med. 81 2003 678 699
121. J.B. Rouget, T. Aksel, J. Roche, J.L. Saldana, A.E. Garcia, D. Barrick, and C.A. Royer Size and sequence and the volume change of protein folding J. Am. Chem. Soc. 133 2011 6020 6027
122. S. Shimizu, and D.J. Smith Preferential hydration and the exclusion of cosolvents from protein surfaces J. Chem. Phys. 121 2004 1148 1154
123. P.N. Atterberry, T.J. Roark, S.Y. Severt, M.L. Schiller, J.M. Antos, and A.R. Murphy Sustained delivery of chemokine CXCL12 from chemically modified silk hydrogels Biomacromolecules 16 2015 1582 1589
124. M.T. Cicerone, M.J. Pikal, and K.K. Qian Stabilization of proteins in solid form Adv. Drug Deliv. Rev. 2015
125. J.F. Carpenter, and J.H. Crowe Modes of stabiliation of a protein by organic solutes during desiccation Cryobiology 25 1988 459 470
126. H.R. Costantino, K. Griebenow, P. Mishra, R. Langer, and A.M. Klibanov Fourier-transform infrared spectroscopic investigation of protein stability in the lyophilized form Biochim. Biophys. Acta Protein Struct. Mol. Enzymol. 1253 1995 69 74
127. A.R. Murphy, and D.L. Kaplan Biomedical applications of chemically-modified silk fibroin J. Mater. Chem. 19 2009 6443 6450
128. F. ranks, R. Hatley, and S. Mathias Materials science and the production of shelf-stable biologicals Biopharm. Technol. Bus. Biopharm. 4 1991 38
129. L. Chang, and M.J. Pikal Mechanisms of protein stabilization in the solid state J. Pharm. Sci. 98 2009 2886 2908
130. P.G. Debenedetti, and F.H. Stillinger Supercooled liquids and the glass transition Nature 410 2001 259 267
131. J.J. Hill, E.Y. Shalaev, and G. Zografi The importance of individual protein molecule dynamics in developing and assessing solid state protein preparations J. Pharm. Sci. 103 2014 2605 2614
132. S. Yoshioka, and Y. Aso Correlations between molecular mobility and chemical stability during storage of amorphous pharmaceuticals J. Pharm. Sci. 96 2007 960 981
133. M.L. Williams, R.F. Landel, and J.D. Ferry The temperature dependence of relaxation mechanisms in amorphous polymers and other glass-forming liquids J. Am. Chem. Soc. 77 1955 3701 3707
134. S.P. Duddu, and P.R. DalMonte Effect of glass transition temperature on the stability of lyophilized formulations containing a chimeric therapeutic monoclonal antibody Pharm. Res. 14 1997 591 595
135. M.T. Cicerone, and J.F. Douglas Beta-relaxation governs protein stability in sugar-glass matrices Soft Matter 8 2012 2983 2991
136. M.J. Pikal, D. Rigsbee, M.L. Roy, D. Galreath, K.J. Kovach, B. Wang, J.F. Carpenter, and M.T. Cicerone Solid state chemistry of proteins: II. The correlation of storage stability of freeze-dried human growth hormone (hGH) with structure and dynamics in the glassy solid J. Pharm. Sci. 97 2008 5106 5121
137. B. Wang, M.T. Cicerone, Y. Aso, and M.J. Pikal The impact of thermal treatment on the stability of freeze-dried amorphous pharmaceuticals: II. Aggregation in an IgG1 fusion protein J. Pharm. Sci. 99 2010 683 700
138. D. Devineni, C. Gonschorek, M.T. Cicerone, Y. Xu, J.F. Carpenter, and T.W. Randolph Storage stability of keratinocyte growth factor-2 in lyophilized formulations: effects of formulation physical properties and protein fraction at the solid-air interface Eur. J. Pharm. Biopharm. 88 2014 332 341
139. M.T. Cicerone, Q. Zhong, and M. Tyagi Picosecond dynamic heterogeneity, hopping, and Johari-Goldstein relaxation in glass-forming liquids Phys. Rev. Lett. 113 2014 117801
140. H. Yu, K. Samwer, Y. Wu, and W. Wang Correlation between β relaxation and self-diffusion of the smallest constituting atoms in metallic glasses Phys. Rev. Lett. 109 2012 095508
141. R.A. Riggleman, J.F. Douglas, and J.J. de Pablo Antiplasticization and the elastic properties of glass-forming polymer liquids Soft Matter 6 2010 292 304
142. L. Yu, X. Hu, D. Kaplan, and P. Cebe Dielectric relaxation spectroscopy of hydrated and dehydrated silk fibroin cast from aqueous solution Biomacromolecules 11 2010 2766 2775
143. F.P. Seib, and D.L. Kaplan Doxorubicin-loaded silk films: drug-silk interactions and in vivo performance in human orthotopic breast cancer Biomaterials 33 2012 8442 8450
144. X. Wang, T. Yucel, Q. Lu, X. Hu, and D.L. Kaplan Silk nanospheres and microspheres from silk/pva blend films for drug delivery Biomaterials 31 2010 1025 1035
145. D.H. Kim, Y.S. Kim, J. Amsden, B. Panilaitis, D.L. Kaplan, F.G. Omenetto, M.R. Zakin, and J.A. Rogers Silicon electronics on silk as a path to bioresorbable, implantable devices Appl. Phys. Lett. 95 2009 133701
146. H.J. Jin, J. Park, V. Karageorgiou, U.J. Kim, R. Valluzzi, P. Cebe, and D.L. Kaplan Water-stable silk films with reduced β-sheet content Adv. Funct. Mater. 15 2005 1241 1247
147. Q. Lu, X. Hu, X. Wang, J.A. Kluge, S. Lu, P. Cebe, and D.L. Kaplan Water-insoluble silk films with silk I structure Acta Biomater. 6 2010 1380 1387
148. R.D. Deegan, O. Bakajin, T.F. Dupont, G. Huber, S.R. Nagel, and T.A. Witten Capillary flow as the cause of ring stains from dried liquid drops Nature 389 1997 827 829
149. N. Guziewicz, A. Best, B. Perez-Ramirez, and D.L. Kaplan Lyophilized silk fibroin hydrogels for the sustained local delivery of therapeutic monoclonal antibodies Biomaterials 32 2011 2642 2650
150. B.S. Chang, and C.S. Randall Use of subambient thermal-analysis to optimize protein lyophilization Cryobiology 29 1992 632 656
151. W. Wang Lyophilization and development of solid protein pharmaceuticals Int. J. Pharm. 203 2000 1 60
152. C. Vepari, and D.L. Kaplan Silk as a biomaterial Prog. Polym. Sci. 32 2007 991
153. E.M. Pritchard, X. Hu, V. Finley, C.K. Kuo, and D.L. Kaplan Effect of silk protein processing on drug delivery from silk films Macromol. Biosci. 13 2013 311 320
154. J. Rnjak-Kovacina, T.M. DesRochers, K.A. Burke, and D.L. Kaplan The effect of sterilization on silk fibroin biomaterial properties Macromol. Biosci. 2015
155. P. Wadbua, B. Promdonkoy, S. Maensiri, and S. Siri Different properties of electrospun fibrous scaffolds of separated heavy-chain and light-chain fibroins of Bombyx mori Int. J. Biol. Macromol. 46 2010 493 501
156. B. Marelli, C.E. Ghezzi, A. Alessandrino, J.E. Barralet, G. Freddi, and S.N. Nazhat Silk fibroin derived polypeptide-induced biomineralization of collagen Biomaterials 33 2012 102 108
157. B.B. Mandal, A. Grinberg, E.S. Gil, B. Panilaitis, and D.L. Kaplan High-strength silk protein scaffolds for bone repair Proc. Natl. Acad. Sci. U. S. A. 109 2012 7699 7704
158. S. Sohn, H.H. Strey, and S.P. Gido Phase behavior and hydration of silk fibroin Biomacromolecules 5 2004 751 757
159. K. Numata, P. Cebe, and D.L. Kaplan Mechanism of enzymatic degradation of beta-sheet crystals Biomaterials 31 2010 2926 2933
160. T. Yucel, P. Cebe, and D.L. Kaplan Vortex-induced injectable silk fibroin hydrogels Biophys. J. 97 2009 2044 2050
161. X. Wang, J.A. Kluge, G.G. Leisk, and D.L. Kaplan Sonication-induced gelation of silk fibroin for cell encapsulation Biomaterials 29 2008 1054 1064
162. Y. Gotoh, M. Tsukada, N. Minoura, and Y. Imai Synthesis of poly(ethylene glycol)-silk fibroin conjugates and surface interaction between L-929 cells and the conjugates Biomaterials 18 1997 267 271
163. V. Karageorgiou, L. Meinel, S. Hofmann, A. Malhotra, V. Volloch, and D. Kaplan Bone morphogenetic protein-2 decorated silk fibroin films induce osteogenic differentiation of human bone marrow stromal cells J. Biomed. Mater. Res. A 71 2004 528 537
164. C.P. Vepari, and D.L. Kaplan Covalently immobilized enzyme gradients within three-dimensional porous scaffolds Biotechnol. Bioeng. 93 2006 1130 1137
165. K.Y. Cai, K.D. Yao, S.B. Lin, Z.M. Yang, X.Q. Li, H.Q. Xie, T.W. Qing, and L.B. Gao Poly(d,l-lactic acid) surfaces modified by silk fibroin: effects on the culture of osteoblast in vitro Biomaterials 23 2002 1153 1160
166. Y.-Q. Zhang, Y. Ma, Y.-Y. Xia, W.-D. Shen, J.-P. Mao, X.-M. Zha, K. Shirai, and K. Kiguchi Synthesis of silk fibroin-insulin bioconjugates and their characterization and activities in vivo J. Biomed. Mater. Res. B Appl. Biomater. 79B 2006 275 283
167. Y.Q. Zhang, W.L. Zhou, W.D. Shen, Y.H. Chen, X.M. Zha, K. Shirai, and K. Kiguchi Synthesis, characterization and immunogenicity of silk fibroin-l-asparaginase bioconjugates J. Biotechnol. 120 2005 315 326
168. Y. Gotoh, M. Tsukada, and N. Minoura Chemical modification of arginyl residues in silk fibroin: 1. Reaction of 1,2-cyclohexanedione in borate buffer Int. J. Biol. Macromol. 14 1992 198 200
169. Y. Tamada Sulfation of silk fibroin by chlorosulfonic acid and the anticoagulant activity Biomaterials 25 2004 377 383
170. A.R. Murphy, P.S. John, and D.L. Kaplan Modification of silk fibroin using diazonium coupling chemistry and the effects on hMSC proliferation and differentiation Biomaterials 29 2008 2829 2838
171. H. Zhao, E. Heusler, G. Jones, L. Li, V. Werner, O. Germershaus, J. Ritzer, T. Luehmann, and L. Meinel Decoration of silk fibroin by click chemistry for biomedical application J. Struct. Biol. 186 2014 420 430
172. D.J. Hines, and D.L. Kaplan Mechanisms of controlled release from silk fibroin films Biomacromolecules 12 2011 804 812
173. E. Wenk, A.R. Murphy, D.L. Kaplan, L. Meinel, H.P. Merkle, and L. Uebersax The use of sulfonated silk fibroin derivatives to control binding, delivery and potency of FGF-2 in tissue regeneration Biomaterials 31 2010 1403 1413
174. A.S. Lammel, X. Hu, S.-H. Park, D.L. Kaplan, and T.R. Scheibel Controlling silk fibroin particle features for drug delivery Biomaterials 31 2010 4583 4591
175. M. Sandor, D. Enscore, P. Weston, and E. Mathiowitz Effect of protein molecular weight on release from micron-sized PLGA microspheres J. Control. Release 76 2001 297 311
176. O. Germershaus, V. Werner, M. Kutscher, and L. Meinel Deciphering the mechanism of protein interaction with silk fibroin for drug delivery systems Biomaterials 35 2014 3427 3434
177. F.P. Seib, G.T. Jones, J. Rnjak-Kovacina, Y. Lin, and D.L. Kaplan pH-dependent anticancer drug release from silk nanoparticles Adv. Healthc. Mater. 2013
178. I. Pallotta, J.A. Kluge, J. Moreau, R. Calabrese, D.L. Kaplan, and A. Balduini Characteristics of platelet gels combined with silk Biomaterials 35 2014 3678 3687
179. J. Brown, C.L. Lu, J. Coburn, and D.L. Kaplan Impact of silk biomaterial structure on proteolysis Acta Biomater. 11 2015 212 221